Clinical Trial Update: Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension [Phase 2]

View source ↗

Summary

Phase 2 study comparing the combination of nifedipine GITS and candesartan against monotherapy in essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Candesartan (candesartan)
• Nifedipine GITS (nifedipine)

Snippet

Sponsor: Bayer | Conditions: Hypertension, Essential | Phase 2 | Status: COMPLETED